相似文献
1
M cell-targeted DNA vaccination.
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9318-23. doi: 10.1073/pnas.161204098. Epub 2001 Jul 17.
2
M cell DNA vaccination for CTL immunity to HIV.
J Immunol. 2003 Nov 1;171(9):4717-25. doi: 10.4049/jimmunol.171.9.4717.
3
Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts.
J Immunol. 1999 Jan 1;162(1):254-62.
4
Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Vaccine. 2011 Feb 24;29(10):1881-90. doi: 10.1016/j.vaccine.2010.12.129. Epub 2011 Jan 13.
5
Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
Arch Virol. 2015 Oct;160(10):2517-24. doi: 10.1007/s00705-015-2535-7. Epub 2015 Jul 28.
6
A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
J Virol. 2015 Aug;89(15):7991-8002. doi: 10.1128/JVI.00803-15. Epub 2015 May 27.
7
Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
J Clin Virol. 2004 Dec;31 Suppl 1:S99-106. doi: 10.1016/j.jcv.2004.09.013.
8
Mucosal immunization with DNA-liposome complexes.
Vaccine. 1997 Jun;15(8):818-20. doi: 10.1016/s0264-410x(96)00278-2.
9
Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
J Virol. 2000 Apr;74(8):3696-708. doi: 10.1128/jvi.74.8.3696-3708.2000.
10
Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope.
Vaccine. 2005 May 31;23(29):3836-42. doi: 10.1016/j.vaccine.2005.02.023. Epub 2005 Mar 17.
引用本文的文献
1
Botulinum Toxin Complex Serotype B-Okra Exerts Systemic Toxicity via the Oral Route by Disrupting the Intestinal Epithelial Barrier.
Toxins (Basel). 2025 Sep 4;17(9):443. doi: 10.3390/toxins17090443.
2
DNA Vaccines: Their Formulations, Engineering and Delivery.
Vaccines (Basel). 2024 Jan 11;12(1):71. doi: 10.3390/vaccines12010071.
3
Intestinal Uptake and Tolerance to Food Antigens.
Front Immunol. 2022 Jun 10;13:906122. doi: 10.3389/fimmu.2022.906122. eCollection 2022.
4
Advances in the polymeric delivery of nucleic acid vaccines.
Theranostics. 2022 May 13;12(9):4081-4109. doi: 10.7150/thno.70853. eCollection 2022.
5
Antigen Sampling -Expressing Epithelial Cells Are the Functional Equivalents of Mammalian M Cells in the Avian Follicle-Associated Epithelium.
Front Immunol. 2019 Oct 22;10:2495. doi: 10.3389/fimmu.2019.02495. eCollection 2019.
6
M Cells: Intelligent Engineering of Mucosal Immune Surveillance.
Front Immunol. 2019 Jul 2;10:1499. doi: 10.3389/fimmu.2019.01499. eCollection 2019.
7
Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1.
Front Immunol. 2018 Feb 28;9:345. doi: 10.3389/fimmu.2018.00345. eCollection 2018.
8
M cell-derived vesicles suggest a unique pathway for trans-epithelial antigen delivery.
Tissue Barriers. 2015 Apr 3;3(1-2):e1004975. doi: 10.1080/21688370.2015.1004975. eCollection 2015.
9
Phenotype and function of nasal dendritic cells.
Mucosal Immunol. 2015 Sep;8(5):1083-98. doi: 10.1038/mi.2014.135. Epub 2015 Feb 11.
10
Mucosal Immunosenescence in the Gastrointestinal Tract: A Mini-Review.
Gerontology. 2015;61(4):336-42. doi: 10.1159/000368897. Epub 2014 Dec 20.
本文引用的文献
1
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
J Infect Dis. 2000 Mar;181(3):1133-7. doi: 10.1086/315323.
2
Gene transfer facilitated by a cellular targeting molecule, reovirus protein sigma1.
Gene Ther. 2000 Jan;7(1):61-9. doi: 10.1038/sj.gt.3301046.
3
Recent advances with recombinant bacterial vaccine vectors.
Mol Med Today. 2000 Feb;6(2):66-71. doi: 10.1016/s1357-4310(99)01633-0.
4
Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
Infect Immun. 1999 Dec;67(12):6249-56. doi: 10.1128/IAI.67.12.6249-6256.1999.
5
6
DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria.
Eur J Immunol. 1999 Mar;29(3):986-96. doi: 10.1002/(SICI)1521-4141(199903)29:03<986::AID-IMMU986>3.0.CO;2-9.
7
A glycosyl hydrolase activity of mammalian reovirus sigma1 protein can contribute to viral infection through a mucus layer.
J Mol Biol. 1999 Feb 26;286(3):759-73. doi: 10.1006/jmbi.1998.2495.
8
Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector.
J Immunol. 1999 Feb 1;162(3):1603-10.
9
Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.
Infect Immun. 1998 Nov;66(11):5470-6. doi: 10.1128/IAI.66.11.5470-5476.1998.
10
Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethylcellulose, augments mucosal antibody production and cell-mediated immune response.
Clin Immunol Immunopathol. 1998 Aug;88(2):205-10. doi: 10.1006/clin.1998.4566.
Zotero 插件